Lifeward Ltd. (LFWD) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good morning and welcome to the first quarter 2026 LifeWord earnings conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing star then zero on your telephone keypad. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Almog Adar, CFO of LifeWord. Please go ahead. Thank you, Drew, and thanks everyone who has joined us on the call today. My name is Almog Adar. I'm LifeWord's Chief Financial Officer, and with me on today's call is our President and Chief Executive Officer, Mark Grant. Earlier this morning, LifeWord issued a press release detailing the financial results for the first quarter ended March 31st, 2026. I would ask you to review the full text of our forward-looking statement from the press release. We anticipate making projections during this call, and actual results could differ materially due to several factors, including those outlined in our latest filing with the SEC. With that, I will turn the call over to Mark. Thank you, Almag, and thank you for everybody for joining us today. The first quarter of 2026 marked an important strategic milestone for LifeWord as we successfully completed the acquisition of Oratex. We believe this transaction significantly strengthens LifeWord's position as a diversified biomedical innovation company while reinforcing our focus on neurorehabilitation and our passport profitability. We believe this was a highly strategic and capital-efficient transaction for LifeWord shareholders. Through the equity-based...